Pharma Expert Witnesses

HIPAA - Healthcare Futurist, HIPAA, data, Consultant, EHR, Pharma, Health Systems, HIEs,

Omar Shaker, MD, MBA is a physician turned clinical data visualization expert, with 3 years of patient care at Tufts and abroad, and a 10-year track record of EHR, decision making, and interoperability consulting. People-focused with exceptional ability to lead emotionally. Extensive clinical data analytics practice working with a wide variety of clinical datasets from payers, health systems, pharma, and HIEs. Successful track record in delivering health data products based on data generated from user research and using design thinking methods. Named one of HIMSS Future 50, and published author and presenter on FHIR at HL7 Roundtables, and AHIMA on clinical data integrity and burnout. Active advisor and angel investor in early-stage digital health startups. Published author and confident speaker, with extensive healthcare network. Omar has 10+ years of experience in consulting US Payers and Providers to improve healthcare using data science and data visualization. Over his career, ...

Pharmaceutical Research, Chemistry & Chemicals - Drug Formulation, Biotechnology, liquid formulation, medicinal chemist, organic chemist, pharmcokinetics, stability studies, dietary supplements, tetracyclines, synthetic biology, breathalyzer, drug tests

EXPERT WITNESS CONSULTING Dr Abato has been involved in 8 cases, been deposed 5 times and has testified at trial in 4 cases. Dr Abato has testified in high stakes litigation cases at the International Trade Commission and federal courts for major players in the pharmaceutical industry. He has experience with ANDA, trade secret, trademark infringement, patent infringement and contract law cases relating to pharmaceuticals. Upload Dr Abato’s CV, which includes a complete list of case numbers and Law Firms that he has represented. PHARMACEUTICAL EXPERIENCE Dr. Abato is a Medicinal Chemist. His expertise includes drug research, medicinal chemistry, organic chemistry, drug formulation for; IT, IV, IP, ICV, IN, IM and oral dosing routs, stability studies, extensive structure-activity relationships, efficacy, pharmacokinetics, as well as all pre-clinical testing required for IND submission to the FDA. Dr Abato was awarded the prestigious “Heroes of Chemistry Award” by the Amer...